drugset / Trial / NCT06557044

The Analgesic Efficacy of Pericapsular Nerve Group (PENG) Block in Patients Undergoing Primary Total Hip Arthoplasty:

NCT06557044 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to investigate the analgesic efficacy of the pericapsular nerve group (PENG) block during the implantation of hip endoprostheses. The study is designed as a prospective randomized double-blind study and the study participants were randomized into 2 arms and either 20 ml ropivacaine 0.5% (verum group) or 20 ml physiological saline solution (placebo group) will be applied.

Timeline

Start
2024-03-07
Primary completion
2025-03
Completion
2025-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 0.5 % —
Subject Ropivacaine Other / unclassified 20 ml —

Indications

No indication recorded.